News

Analysts at ING noted that the Fed’s September meeting could be "explosive," as it may be the latest episode in Powell’s ongoing "tug-of-war" with Trump, who has criticized the Fed leader for not ...
Investing.com -- Brazilian oil company Prio announced Monday that Brazil’s national petroleum regulator ANP has ordered a production halt at the Peregrino FPSO. The regulator cited the need for ...
Here are some of the biggest premarket U.S. stock movers today: Palo Alto Networks (NASDAQ: PANW) stock rose 0.4%, with the ...
A penny stock touched its upper circuit after announcing fresh project wins. Investor sentiment turned positive despite subdued quarterly earnings, with the new orders expected to boost its execution ...
Lemon Tree Hotel’s subsidiary, Fleur Hotels Limited, has received a Letter of Award (LOA) from the Delhi Development Authority (DDA) for a 2.256-acre land parcel at Nehru Place, New Delhi. The LOA, ...
Investors will turn their focus this week to Jackson Hole, Wyoming, where Federal Reserve officials convene for the annual policy symposium, seeking signals on the pace of rate cuts that have helped ...
Investing.com -- China National Aviation Fuel Company (CNAF) announced on Monday it has agreed to acquire a stake in a sustainable aviation fuel plant controlled by Henan Junheng Industry Group ...
The initiative aims to boost Thailand’s vital tourism sector by providing visitors with an additional payment option. Finance Ministry permanent secretary Lavaron Sangsnit told reporters that ...
Investing.com -- U.S. stock index futures slipped slightly lower Monday, pausing for breath after a positive week as ...
Investing.com -- Hon Hai Precision Industry Co. will operate a US factory owned by SoftBank Group Corp., positioning it as a potential first manufacturing site for the $500 billion Stargate venture ...
At the beginning of August, they received an AI-picked list of stocks ( available now for less than $9 a month as part of our limited-time only summer sale) with as many as THREE names that went on to ...
Wegovy becomes the first GLP-1 based therapy authorized for MASH, which affects roughly 5% of U.S. adults, according to the ...